Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide. Offering clients a complete concept-to-commercialization solution, we’ve recently expanded our capacity, and added equipment and people to deliver excellence and flexibility for solid oral dosage forms. With an invigorated focus on our dynamic industry, we invite you to learn why we’re stronger by any metric.
Pharmaceutical Development and Clinical Trial Materials Manufacturing
We offer comprehensive formulation development services from preclinical through Phase III CTM including: tableting, immediate release, modified release (including controlled/matrix and sustained release), capsule filling, milling, micronizing, enteric coating, spray drying, extrusion, and spheronization. Our facilities and processes are designed to handle potent products, cytotoxic compounds, and controlled substances.
With more than 125 chemists on staff, Metrics Contract Services analyzes the physical and chemical characteristics of drug substances and drug products through development and validation of methods, release and stability testing. We perform this work in compliance with industry standards and international regulatory guidelines.
Our potent facilities provide total engineered containment through customized, hardwall isolation technologies. Containment is achieved at 30 nanograms per cubic meter of room air; equipment and change parts are dedicated exclusively to potent use. The facility features independent entry, exit and equipment double airlocks, decontamination showers, dedicated washroom, dedicated equipment storage and pass through for product/waste.
Fast Track First Time In Man (FTIM) Studies
Metrics Contract Services has successfully delivered materials for over 150 FTIM studies. Our process ensures speed and quality, with a 16-24 week timeline from receipt of well-characterized NCE to shipment to the clinic. Services include stability studies, analytical methods development and validation. Choose simple formulation, blended powder in capsule, or neat API in a bottle.
The parent company of Metrics Contract Services, Mayne Pharma, recently invested $80 million to significantly expand facilities and equipment at its site in Greenville, NC. The new 126,000 sq. ft. oral dose commercial manufacturing facility quadruples the company’s US manufacturing capacity, and the repurposing of existing space creates 10+ new analytical laboratories and formulation development suites.
Metrics Contract Services can now offer a complete concept-to-commercialization solution in one contiguous location for clients, providing larger scale and increased capabilities for seamless scale-up, eliminating the need for site transfers.
Posted Date: 11/25/2019
This record has been viewed 357 times.